FOXK2 and osteosarcoma: FOXK2 is highly expressed in chronic lymphocytic leukemia (CLL), metastatic breast cancer (MBC), and osteosarcoma clusters and corresponds to poor outcomes in melanoma and non‐small cell lung cancer (NSCLC) cohorts.